The transcription factor KLF4 as an independent predictive marker for pathologic complete remission in breast cancer neoadjuvant chemotherapy: a case–control study

BACKGROUND: To identify whether a stem cell biomarker, KLF4, may predict the pathologic tumor response to neoadjuvant chemotherapy for patients with locally advanced breast cancer. METHODS: Twelve locally advanced breast cancer patients who achieved pathologic complete remission (pCR) after neoadjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Min Jun, Wang, Lin Bo, Jiang, Zhi Nong, Jin, Mei, Hu, Wen Xian, Shen, Jian Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216037/
https://www.ncbi.nlm.nih.gov/pubmed/25368523
http://dx.doi.org/10.2147/OTT.S68340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216037/
https://www.ncbi.nlm.nih.gov/pubmed/25368523
http://dx.doi.org/10.2147/OTT.S68340

Ejemplares similares